Get startedLog in
    Picture of Everest Medicines logo

    1952 — Everest Medicines Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-1,009-247-844-1,041-598
    Depreciation
    Amortisation
    Non-Cash Items184-95166.5354350
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital63.2-0.323-68-126-1.22
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-730-1,156-769-680-92.6
    Capital Expenditures-976-433-266-204-348
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items—-5951,0181,179-344
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-976-1,028752974-693
    Financing Cash Flow Items——-7.95-19.7-22.4
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-76.5-25.310.137.81,773
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1,841-2,14932.3361960